Immunogenicity of COVID-19 Vaccines Against Coronavirus Disease (COVID-19) Among Tuberculosis (TB) Patients in Thailand-Myanmar Border.
Latest Information Update: 28 Feb 2025
At a glance
- Drugs Ad26.COV2 S (Primary) ; AZD 1222 (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Therapeutic Use
Most Recent Events
- 24 Feb 2025 Planned End Date changed from 14 Dec 2024 to 31 Dec 2025.
- 24 Feb 2025 Planned primary completion date changed from 14 Dec 2024 to 31 Dec 2025.
- 09 May 2024 Planned End Date changed from 14 Apr 2024 to 14 Dec 2024.